Accountability is one of our core values throughout Mallinckrodt, and we are steadfast in our commitment to integrity and high ethical standards. Our goal is to provide effective solutions for healthcare professionals and their patients.
Our goal is to help enhance the quality of care for patients by delivering innovative and trusted solutions to you—such as the automated intelligence of our RFID-enabled UltrajectTM prefilled syringes with RFID-enabled OptivantageTM dual-head CT contrast delivery system that helps support relevant guidelines from The Joint Commission’s Medication Management Standards and the U.S. Pharmacopeia <797>, while reducing certain risk in the radiology department.
Our Liebel-Flarsheim™ urology imaging system offers safety and comfort attributes from both a radiological and procedural perspective. Our OptivantageTM dual-head CT contrast delivery system with Optibolus™ may allow you to more effectively manage your contrast media usage. Ethically, we believe that safety means transparency. With that in mind, we employ a rigorous process that helps ensure that our prescribing information is updated with the most recent safety information.
Mallinckrodt, the 'M' brand mark, the Mallinckrodt Pharmaceuticals logo and other brands are trademarks of a Mallinckrodt company.
© 2017 Mallinckrodt. Mallinckrodt Pharmaceuticals is a registered business name of Mallinckrodt plc, which is registered in Ireland as a public limited company with registration number 522227 and has its registered office at College Business & Technology Park, Cruiserath, Blanchardstown, Dublin 15, Ireland.